NOVEL COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

摘要

The present invention relates to novel inhibitors of prolyl endopeptidase of formula (I): W-KCONH-X-CON-Y-CO-Z, wherein K, W; X, Y and Z are specified in the description. The compounds are useful for the treatment of diseases such as mild cognitive impairment (MCI), Alzheimer's disease. Down Syndrome, Parkinson disease and Chorea Huntington.